Entest Biomedical Inc (ETNI)
Entest Biomedical Inc. (ETNI) is listed on OTC Markets as a common stock security. The company, now known as Entest Group, Inc., has no significant operating business. Its stated focus is to identify and evaluate potential business opportunities with the aim of completing a merger, acquisition, or similar combination with an operating company. The issuer was founded in 2008 and is based in Shenzhen, China. In February 2018, it changed its name from Entest Biomedical, Inc. to Entest Group, Inc.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ETNI
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
9.834 K
|
—
|
—
|
—
|
—
|
—
|
—
|
